NCS1

Neuronal calcium sensor 1 · P62166 · NCS1 on Sugi Atlas →

988 patent compounds predicted against NCS1, 752 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL17287798 SCHEMBL17287798 1.00 1/20
SCHEMBL17287822 SCHEMBL17287822 0.75 1/20
SCHEMBL6766057 SCHEMBL6766057 0.70 1/20
SCHEMBL13949524 SCHEMBL13949524 0.67 1/20
SCHEMBL4858014 SCHEMBL4858014 0.66 1/20
SCHEMBL5313704 SCHEMBL5313704 0.66 1/20
SCHEMBL6206186 SCHEMBL6206186 0.66 1/20
SCHEMBL7933388 SCHEMBL7933388 0.66 1/20
Ethylene Ethylene (SCHEMBL8167289) 0.66 1/20
SCHEMBL2431114 SCHEMBL2431114 0.65 1/20
SCHEMBL19612098 SCHEMBL19612098 0.65 1/20
SCHEMBL17770327 SCHEMBL17770327 0.64 1/20
SCHEMBL3933070 SCHEMBL3933070 0.64 1/20
SCHEMBL5070926 SCHEMBL5070926 0.64 1/20
SCHEMBL1580942 SCHEMBL1580942 0.64 1/20
SCHEMBL5184333 SCHEMBL5184333 0.64 1/20
SCHEMBL17287819 SCHEMBL17287819 0.64 1/20
SCHEMBL11887784 SCHEMBL11887784 0.64 1/20
SCHEMBL4862601 SCHEMBL4862601 0.63 1/20
SCHEMBL18289908 SCHEMBL18289908 0.63 1/20

Clinical trials — most relevant to NCS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Minocycline for the Treatment of Early-Phase Schizophrenia PHASE3COMPLETED
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction PHASE2ACTIVE_NOT_RECRUITING
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease PHASE2COMPLETED
A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome PHASE1/PHASE2NOT_YET_RECRUITING
Vibration Therapy Effects on Muscle Firing Patterns PHASE1/PHASE2COMPLETED
EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions PHASE2COMPLETED
TRPM8 Activators for Peripheral Neuropathy PHASE2ACTIVE_NOT_RECRUITING
Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain PHASE2COMPLETED
The Energetic Origin of Neurodegeneration in MS nanCOMPLETED
Pain Processing and Pain Neuroscience Education in Children With Chronic Abdominal Pain nanCOMPLETED
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia nanCOMPLETED
Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients nanRECRUITING
Measuring Single Neuron Activity in the Brain nanNOT_YET_RECRUITING
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) nanNOT_YET_RECRUITING
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
Long Term Transcranial Pulse Stimulation (TPS) on Older Adults With Mild Neurocognitive Disorder (NCD) nanUNKNOWN
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Urine Concentration of S100B in Extremely Premature Infants nanCOMPLETED
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Exploring the Genetics of Neuropathic Pain nanRECRUITING
Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity nanCOMPLETED
Effects of Photobiomodulation on the Innate Immune System of Neonates and Infants With Bronchiolitis nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
BIOmarkers of MIGraine: a Proof of Concept Study Based on the Stratification of Responders to CGRP Monoclonal Antibodies nanCOMPLETED
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED
SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom nanRECRUITING
Neurogenic Mechanisms in Burning Mouth Syndrome nanCOMPLETED
EXploring novEl Molecular Determinants of DRAvet Syndrome Phenotype Heterogeneity nanUNKNOWN
Duration of Analgesia in Bier Block for Patients Undergoing Hand Surgery nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NCS1 binder may also engage these)

ProteinNameSimilarity
Q5RC90 1.000 Q5RC90 →
Q2V8Y7 1.000 Q2V8Y7 →
P62167 1.000 P62167 →
Q8BNY6 1.000 Q8BNY6 →
Q91614 1.000 Q91614 →
P62762 1.000 P62762 →
Q5R6S5 1.000 Q5R6S5 →
P36608 1.000 P36608 →
P62168 1.000 P62168 →
Q4R5F7 0.998 Q4R5F7 →
P37236 0.998 P37236 →
Q9VWX8 0.998 Q9VWX8 →
Q06389 0.997 Q06389 →
Q3YLA4 0.997 Q3YLA4 →
Q16981 0.997 Q16981 →
P29105 0.997 P29105 →
Q28IM6 0.996 Q28IM6 →
P37235 0.996 P37235 →
Q6DCM9 0.996 Q6DCM9 →
P62748 0.995 P62748 →
P29104 0.995 P29104 →
Q09711 0.995 Q09711 →
P35332 0.994 P35332 →
Q9UM19 0.994 Q9UM19 →
P62760 0.994 P62760 →
B3VSB7 0.994 B3VSB7 →
Q06AT0 0.994 Q06AT0 →
B5FZ84 0.994 B5FZ84 →
Q7SY75 0.994 Q7SY75 →
Q4PL64 0.993 Q4PL64 →